drugset / Trial / NCT04361305

Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction

NCT04361305

Phase 3 Unknown 150 enrolled Yan-Ping Huang
RandomizedParallel-groupOpen-labelTreatment

Summary

Premature ejaculation (PE) is a common disease in the andrology clinic. Currently, the effectiveness and outcome differences of drug treatment still need to be studied and demonstrated. Premature ejaculation concurrent with erectile dysfunction (ED) is common in outpatient clinics. The preferred treatment plan for these patients still needs to be further studied and explored, and the difference in the efficacy of different treatment regiments remain to be evaluated.

Timeline

Start
2020-06-03
Primary completion
2021-01-11
Completion
2021-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapoxetine Small molecule 30 mg
Subject Tadalafil Small molecule 5 mg